Literature DB >> 12414033

Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance.

Enrico Ruffini1, Ottavio Rena, Alberto Oliaro, Pier Luigi Filosso, Massimo Bongiovanni, Anna Arslanian, Esther Papalia, Giuliano Maggi.   

Abstract

OBJECTIVE: To analyze and compare clinico-pathologic characteristics and survival between lung tumors with mixed histologic pattern and our population of resected lung tumors with single histology in the same period.
METHODS: From January 1993 to December 1999, 1158 patients received resection for lung tumors. Of these, 59 (5.1%) presented a mixed histologic pattern on the surgical specimen. There were 48 men and 11 women (mean age 64 years, range 43-79). Three groups of tumors were identified: adenosquamous carcinoma, combined neuroendocrine + non-neuroendocrine carcinoma (NNEC) and biphasic tumors (epithelial + mesenchymal malignant components) represented by carcinosarcoma and blastoma. The combined neuroendocrine tumors were further divided in small cell lung carcinoma (SCLC) + large cell neuroendocrine carcinoma (LCNEC)/NNEC and other neuroendocrine tumors/NNEC. Clinico-pathologic characteristics, pTNM and survival were analyzed and compared to our population of resected lung tumors with single histology.
RESULTS: There were 33 adenosquamous carcinomas, 19 combined SCLC+LCNEC/NNEC, two other neuroendocrine tumors/NNEC and five biphasic tumors (three carcinosarcomas and two blastomas). Among adenosquamous carcinomas, high cell grading (G2 or G3), advanced stage (IIIa or higher) and intratumoral perineural invasion were significantly more evident than in the single histology population. Among combined neuroendocrine/NNEC, high cell grading (G3) and intratumoral vascular invasion were significantly more evident than in the single histology population. Among biphasic tumors, all were at early stages and showed high cell grading (G3). Three-year survival rates were 46% in the single histology group, 28% in the adenosquamous group and 21% in the combined SCLC + LCNEC/NNEC. The difference among the three groups was significant (P = 0.013). Median survival of biphasic tumors was 19 months (range 8-37).
CONCLUSIONS: Lung tumors with mixed histologic pattern are rare tumors. Adenosquamous carcinoma and combined SCLC + LCNEC/NNEC present a more aggressive clinico-pathologic behaviour and reduced survival as compared to the single histology population of resected lung tumors. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Year:  2002        PMID: 12414033     DOI: 10.1016/s1010-7940(02)00481-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  26 in total

Review 1.  Primary combined squamous and small cell carcinoma of the larynx: Report of two cases and discussion of treatment modalities.

Authors:  Annelore Barbeaux; Lionel Duck; Birgit Weynand; Gauthier Desuter; Marc Hamoir; Vincent Gregoire; Jean-François Baurain; Jean-Pascal Machiels
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-23       Impact factor: 2.503

Review 2.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

3.  Clinicopathological characteristics and prognosis of patients with adenosquamous lung carcinoma.

Authors:  Ye Guo; Lin Jia; Guo-Guang Shao; Hong-Wei Sun; Xing-Xing Wang; Guan-Jun Wang; Ke-Wei Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

4.  Cutaneous metastasis from pulmonary large cell neuroendocrine carcinoma in the scalp.

Authors:  Mitsuaki Ishida; Muneo Iwai; Akiko Kagotani; Nozomi Iwamoto; Hidetoshi Okabe
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

5.  Bone metastasis from lung cancer identified by genetic profiling.

Authors:  Zhu-Lin Liu; Chun Wang; Hui-Jiao Chen; Xue Li; Li-Jun Dai; Zhen-Yu Ding
Journal:  Oncol Lett       Date:  2016-12-02       Impact factor: 2.967

6.  Combined large cell neuroendocrine carcinoma.

Authors:  Toshiya Bessho; Keiya Yokochi; Teruhisa Sakurai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-09

7.  Combined small cell carcinoma with giant cell carcinoma component of the lung: A case successfully diagnosed by computed tomography-guided fine-needle aspiration cytology.

Authors:  Yusuke Ebisu; Mitsuaki Ishida; Tomohito Saito; Tomohiro Murakawa; Yoshiko Uemura; Koji Tsuta
Journal:  Oncol Lett       Date:  2017-11-20       Impact factor: 2.967

Review 8.  Large cell neuroendocrine carcinoma of the ampulla of Vater with glandular differentiation.

Authors:  S-P Cheng; T-L Yang; K-M Chang; C-L Liu
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma.

Authors:  Giovanni Fellegara; Tiziana D'Adda; Francesco P Pilato; Elisabetta Froio; Luca Ampollini; Michele Rusca; Guido Rindi
Journal:  Virchows Arch       Date:  2008-06-13       Impact factor: 4.064

10.  Adenosquamous cell lung cancer successfully treated with gefitinib: A case report.

Authors:  Koichi Kurishima; Gen Ohara; Katsunori Kagohashi; Hiroko Watanabe; Norio Takayashiki; Atsushi Ishibashi; Hiroaki Satoh
Journal:  Mol Clin Oncol       Date:  2013-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.